Literature DB >> 26953259

Regulatory Implications of Non-Trivial Splicing: Isoform 3 of Rab1A Shows Enhanced Basal Activity and Is Not Controlled by Accessory Proteins.

Patricia Schöppner1, Gergely Csaba2, Tatjana Braun1, Marina Daake1, Bettina Richter1, Oliver F Lange1, Martin Zacharias3, Ralf Zimmer4, Martin Haslbeck5.   

Abstract

Alternative splicing often affects structured and highly conserved regions of proteins, generating so called non-trivial splicing variants of unknown structure and cellular function. The human small G-protein Rab1A is involved in the regulation of the vesicle transfer from the ER to Golgi. A conserved non-trivial splice variant lacks nearly 40% of the sequence of the native Rab1A, including most of the regulatory interaction sites. We show that this variant of Rab1A represents a stable and folded protein, which is still able to bind nucleotides and co-localizes with membranes. Nevertheless, it should be mentioned that compared to other wild-typeRabGTPases, the measured nucleotide binding affinities are dramatically reduced in the variant studied. Furthermore, the Rab1A variant forms hetero-dimers with wild-type Rab1A and its presence in the cell enhances the efficiency of alkaline phosphatase secretion. However, this variant shows no specificity for GXP nucleotides, a constantly enhanced GTP hydrolysis activity and is no longer controlled by GEF or GAP proteins, indicating a new regulatory mechanism for the Rab1A cycle via alternative non-trivial splicing.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Rab1A; non-trivial splicing; protein folding; protein secretion

Mesh:

Substances:

Year:  2016        PMID: 26953259     DOI: 10.1016/j.jmb.2016.02.028

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  1 in total

1.  Expression analysis and implication of Rab1A in gastrointestinal relevant tumor.

Authors:  Menglin Xu; Xinyu Shao; Xiaoyi Kuai; Liping Zhang; Chunli Zhou; Zhengwu Cheng
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.